s-nitrosocaptopril has been researched along with Disease Models, Animal in 2 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Chen, J; Chen, W; Han, L; Jia, L; Li, F; Lin, M; Shao, JW; Wang, C; Wang, J; Zhou, Y | 1 |
| Gambino, A; Tsui, DY; Wanstall, JC | 1 |
2 other study(ies) available for s-nitrosocaptopril and Disease Models, Animal
| Article | Year |
|---|---|
A novel S-nitrosocaptopril monohydrate for pulmonary arterial hypertension: H
Topics: Animals; Antihypertensive Agents; Aorta; Captopril; Crystallization; Disease Models, Animal; Endothelium, Vascular; Heart Ventricles; Humans; Hypertension, Pulmonary; Male; Nitric Oxide Donors; Rats; Rats, Sprague-Dawley; Sodium Nitrite; Stomach; Tissue Culture Techniques; Vascular Resistance; Vasodilation; Vasodilator Agents | 2018 |
S-nitrosocaptopril: acute in-vivo pulmonary vasodepressor effects in pulmonary hypertensive rats.
Topics: Administration, Oral; Animals; Captopril; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Injections, Intravenous; Lung; Male; Rats; Rats, Wistar; Time Factors; Vasoconstrictor Agents; Vasodilation | 2003 |